Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2018

Nov 09, 2018

SELL
$38.6 - $46.12 $1.42 Million - $1.69 Million
-36,700 Reduced 68.86%
16,600 $705,000
Q2 2018

Aug 08, 2018

BUY
$40.56 - $51.36 $2.16 Million - $2.74 Million
53,300 New
53,300 $2.19 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.53B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.